This small cap looks like a take over and they have a drug Surfaxin in final stages for FDA approval- the drug if approved will be used in the prevention of Respiratory Distress Syndrome (RDS) in premature infants. I like preventative medicine and with new emphasis on staying healthy - these medications will gain favor over treatments as pressure to reduce costs come into play. closed yesterday at $1.11 52 week range .3250-2.40. Maybe a take over target? interested in your thoughts-

r/
wired